Daily as of 3 Nov 16:00 ET
- Price
- below both $305.03 vs 50 $335.72 / 200 $308.70
- Projection
- 💀Death cross estimated in 20 to 30 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 13 Oct 2025 · projected 24 bars out
KRYS | Krystal BiotechNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$305.03
+$9.13 (+3.09%)
Krystal Biotech (KRYS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Oct 2025, but the two have been closing on each other and a death cross is projected within 30 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $332.29 vs 50 $297.28 / 200 $182.29
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- below both $305.03 vs 50 $322.30 / 200 $340.25
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 12 Oct 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 12 Oct 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| 13 Oct 2025 | 🟨Golden steep | daily | 24 bars out | Not tested |
| 25 Aug 2025 | 🟨Golden | 4-hour | 4 bars out | — |
| 6 May 2025 | 💀Death | 4-hour | 26 bars out | — |
| 12 Mar 2025 | 🟨Golden | 4-hour | 30 bars out | — |
About KRYS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$76.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandlarge